Beijing Centergate Technologies (holding) Co., Ltd. (SHE:000931)

China · Delayed Price · Currency is CNY

4.430

+0.060 (1.37%)

Sep 14, 2026, 3:04 PM CST

Market Cap	3.34B -17.7%
Revenue (ttm)	2.21B -11.5%
Net Income	-20.72M
EPS	-0.03
Shares Out	753.13M
PE Ratio	n/a
Forward PE	n/a
Dividend	0.02 (0.44%)
Ex-Dividend Date	Jun 12, 2026

Volume	12,682,496
Open	4.330
Previous Close	4.370
Day's Range	4.330 - 4.430
52-Week Range	3.760 - 5.960
Beta	0.31
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 22, 2026

About SHE:000931

Beijing Centergate Technologies (holding) Co., Ltd. engages in the production and sale of topical reagents, tablets, injections in China. The company offers Anemarrhena saponin BII and capsules for vascular dementia treatment; Naltrexone Hydrochloride tablets and injections to block the pharmacological effects of exogenous opioids; Acetaminophen and oxycodone tablets and injections for the treatment of moderate to severe pain; tramadol hydrochloride tablets and injections to treat pain in adults; aprolol hydrochloride for the treatment of hyper... [Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

Founded 1999

Employees 2,267

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 000931

Full Company Profile

Financial Performance

In 2025, SHE:000931's revenue was 2.44 billion, a decrease of -3.52% compared to the previous year's 2.53 billion. Earnings were 47.89 million, a decrease of -10.65%.

Financial Statements